BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 19848607)

  • 1. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
    Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
    J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease.
    Kao J; Kobashigawa J; Fishbein MC; MacLellan WR; Burdick MD; Belperio JA; Strieter RM
    Circulation; 2003 Apr; 107(15):1958-61. PubMed ID: 12695288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
    Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
    J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
    Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
    J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
    Zeremski M; Petrovic LM; Talal AH
    J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.
    Zeremski M; Petrovic LM; Chiriboga L; Brown QB; Yee HT; Kinkhabwala M; Jacobson IM; Dimova R; Markatou M; Talal AH
    Hepatology; 2008 Nov; 48(5):1440-50. PubMed ID: 18798334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
    Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
    Berres ML; Trautwein C; Schmeding M; Eurich D; Tacke F; Bahra M; Neuhaus P; Neumann UP; Wasmuth HE
    Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives.
    Chuang YH; Lian ZX; Cheng CM; Lan RY; Yang GX; Moritoki Y; Chiang BL; Ansari AA; Tsuneyama K; Coppel RL; Gershwin ME
    J Autoimmun; 2005 Sep; 25(2):126-32. PubMed ID: 16243485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].
    Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
    Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
    Chen CH; Lin ST; Kuo CL; Nien CK
    Hepatogastroenterology; 2008; 55(85):1423-7. PubMed ID: 18795704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.
    Bièche I; Asselah T; Laurendeau I; Vidaud D; Degot C; Paradis V; Bedossa P; Valla DC; Marcellin P; Vidaud M
    Virology; 2005 Feb; 332(1):130-44. PubMed ID: 15661146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.
    Berenguer J; Fernandez-Rodríguez A; Jimenez-Sousa MA; Cosín J; Zarate P; Micheloud D; López JC; Miralles P; Catalán P; Resino S
    Cytokine; 2012 Jan; 57(1):25-9. PubMed ID: 22136974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
    Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
    Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease.
    Apolinario A; Majano PL; Alvarez-Pérez E; Saez A; Lozano C; Vargas J; García-Monzón C
    Am J Gastroenterol; 2002 Nov; 97(11):2861-70. PubMed ID: 12425561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.
    Forns X; Ampurdanès S; Llovet JM; Aponte J; Quintó L; Martínez-Bauer E; Bruguera M; Sánchez-Tapias JM; Rodés J
    Hepatology; 2002 Oct; 36(4 Pt 1):986-92. PubMed ID: 12297848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection.
    Chalin A; Lefevre B; Devisme C; Barget N; Amiot L; Samson M
    Cytokine; 2019 May; 117():72-78. PubMed ID: 30826602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.